JON MALAN: Open Payments
NPI 1306842232 · POCATELLO, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$180 in 11 payments from 7 companies in 2025. Trend: 2023 $76 · 2024 $273 · 2025 $180
Food & beverage: $180
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $49 |
| Neurocrine BioSciences, Inc. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 2 | $28 |
| Exact Sciences Corporation | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
| Lundbeck LLC | 1 | $16 |
| Corium, LLC | 1 | $12 |
Products named: FANAPT, INGREZZA, AUSTEDO XR, Cologuard Collection Kit, VRAYLAR, REXULTI, Azstarys.
Industry payments across ID — which companies pay providers there.
